• Skip to main content

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

News

News

SK Capital Partners / August 9, 2017

Aug 09, 2017 / Tri-Tex

Tri-Tex welcomes Julian Steinberg and W. Dexter Brown to its Board of Directors

Montreal, August 1, 2017 - Tri-Tex, a leading producer of high performance specialty chemicals, is pleased to announce that Messrs. Julian Steinberg and W. …

➞

SK Capital Partners / August 8, 2017

Aug 08, 2017 / AEB Group

AEB Group Completes Acquisition of Innotec

BRESCIA, August 3, 2017 – AEB Group, a portfolio company of SK Capital and a global leader in biotechnology solutions for winemakers, beer brewers, and other …

➞

RuthAnne Dreisbach / June 26, 2017

Jun 26, 2017 / Halo Pharmaceutical

Halo Pharma Welcomes Itzhak Krinsky, Ph.D. to Its Board of Directors

Whippany, NJ, June 26, 2017 – Halo Pharma, a rapidly growing Contract Development and Manufacturing Organization (CDMO), is pleased to announce that Dr. Itzhak …

➞

SK Capital Partners / June 1, 2017

Jun 01, 2017 / Foremark

SK Capital Acquires D.B. Western, Inc. – Texas; Changes Name to Foremark Performance Chemicals

NEW YORK, June 1, 2017 – SK Capital Partners, a private investment firm with a disciplined focus on the specialty materials, chemicals and pharmaceutical …

➞

SK Capital Partners / June 1, 2017

Jun 01, 2017 / Tri-Tex

SK Capital Closes Control Investment in Tri-Tex to Support Continued Business Growth

NEW YORK, June 1, 2017 – SK Capital Partners, a private investment firm with a disciplined focused on the specialty materials, chemicals and pharmaceutical …

➞

RuthAnne Dreisbach / February 2, 2017

Feb 02, 2017 / Niacet

SK Capital Closes Acquisition of Niacet Corporation

NEW YORK, February 2, 2017 - SK Capital Partners, a private investment firm with a disciplined focus on the specialty materials, chemicals, and pharmaceuticals …

➞

  • ➞
  • Go to page 1
  • Interim pages omitted …
  • Go to page 16
  • Go to page 17
  • Go to page 18
  • Go to page 19
  • Go to page 20
  • Interim pages omitted …
  • Go to page 25
  • ➞

© 2023 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login